The World Health Organization has announced the theme for World Patient Safety Day 2024 (September 17) as “Improving diagnosis for patient safety.” World Patient Safety Day is the cornerstone of action to promote global health and safety. It is firmly grounded in the fundamental principle of medicine, “first do no harm.”
To improve diagnostic safety, the main objective for patients and families is to actively engage with health workers and healthcare leaders to improve diagnostic processes.
Here’s what you can do:
Understand and engage in the diagnostic journey.
Ensure you understand the diagnostic process, including the steps that you and your healthcare team will take to determine your diagnosis.
Engage actively with your healthcare team by sharing accurate and comprehensive information about your symptoms and medical history from the start.
Prompt your healthcare team to think comprehensively about alternative diagnoses, such as by asking “What else could it be?”
Ask about the purpose, potential risks, alternatives, and follow-up steps of any recommended diagnostic interventions.
Keep track of your health, symptoms, medical visits, and treatments.
Be informed about the expected progression of your illness, potential danger signs, and how to access care if your condition either does not improve or worsens.
Adhere to prescribed treatment plans and attend follow-up appointments.
Ensure continuity, accuracy, and validity of information.
Ask your healthcare team for information and use reliable medical information sources.
Follow up on the results of your diagnostic tests and proactively ask for the report; no news is not always good news.
Don’t be afraid to seek a second opinion if you have any doubts or uncertainties about the initial diagnosis.
Regularly check your health records to ensure that all information is documented, accurate, and up to date.
Speak up with concerns about your diagnosis and care.
Raise any concerns you may have about your diagnosis or the diagnostic process.
A mother picked up a refill of her child's medicine, Strattera (atomoxetine), a drug used to treat attention-deficit/hyperactivity disorder (ADHD). The capsules were a different color than what they previously received. Even though the prescription bottle said Strattera 60 mg, the mother called the pharmacy to check.
In February, the Chicago Sun Times reported that 16 elementary school children had been taken to local hospitals with a sudden illness. The children were 9- and 10-year olds who began vomiting after eating “mints” given to them by another classmate. It was later found that these “mints” were actually nicotine -replacement lozenges, called NiQuitin Minis ( Figure 1 on page 3). ( NiQuitin is a product from the United Kingdom that is sold online; however, the Nicorette brand made in the US has a similar product.) The classmate found the lozenges at home and brought them to school to share.
